{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5f2442bc6de29f32c4d05451/699482e8b1ca974bbc228012?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"The BRAIN miniseries | Investigating the link between vascular health and neurodegeneration in underrepresented populations ","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5f2442bc6de29f32c4d05451/1771340334258-72b6d228-cce1-4359-8fa5-9daa7a23f31f.jpeg?height=200","description":"<p><strong>In our second episode of the BRAIN (Black Researchers Addressing Inequalities in Neuroscience)&nbsp;podcast miniseries, we explore&nbsp;the lab techniques and interdisciplinary approaches being leveraged to understand how vascular health impacts neurodegeneration, particularly in underrepresented&nbsp;populations.&nbsp;</strong></p><p><br></p><p>Our guest is <a href=\"https://www.cellashayes.com/\" rel=\"noopener noreferrer\" target=\"_blank\">Cellas Hayes</a>, a neuroepidemiologist and postdoctoral researcher at <a href=\"https://med.stanford.edu/\" rel=\"noopener noreferrer\" target=\"_blank\">Stanford University School of</a> Medicine (CA, USA), whose work traverses brain aging, Alzheimer's disease and vascular health,&nbsp;with a particular focus on blood-based biomarkers, white matter disease&nbsp;and cognitive aging across diverse populations. Using large, deeply phenotyped cohorts, Cellas studies how different modifiable and cardiometabolic risk factors shape brain health long before clinical dementia emerges. Beyond research, Cellas is strongly engaged in mentorship, grant writing and building equitable pathways in aging and neuroscience research.</p>","author_name":"BioTechniques"}